Multiple Sclerosis Research Today is a free monthly online journal that collates and summarizes the latest research about Multiple Sclerosis, including details on diagnosis, symptoms, treatment, prognosis.

Volume 3 (2006), Issue 3 (March)

1. Natalizumab plus interferon beta-1a for relapsing multiple sclerosis.
   N Engl J Med, 354(9): 911-23. [Abstract] [Full-text]
2. A randomized, placebo-controlled trial of natalizumab for relapsing multiple sclerosis.
   N Engl J Med, 354(9): 899-910. [Abstract] [Full-text]
3. Evoked potential studies in the antiphospholipid syndrome: differential diagnosis from multiple sclerosis.
   Ann Rheum Dis, 65(4): 525-8. [Abstract] [Full-text]
4. Ventricular enlargement in MS: one-year change at various stages of disease.
   Neurology, 66(5): 693-8. [Abstract] [Full-text]
5. Gray and white matter brain atrophy and neuropsychological impairment in multiple sclerosis.
   Neurology, 66(5): 685-92. [Abstract] [Full-text]
6. IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
   Neurology, 66(5): 678-84. [Abstract] [Full-text]
7. Secondary progressive multiple sclerosis: current knowledge and future challenges.
   Lancet Neurol, 5(4): 343-54. [Abstract] [Full-text]
8. Pediatric multiple sclerosis.
   NeuroRx, 3(2): 264-75. [Abstract] [Full-text]
9. A Phase II study of the safety and efficacy of teriflunomide in multiple sclerosis with relapses.
   Neurology, 66(6): 894-900. [Abstract] [Full-text]
10. CD4+ regulatory T cell responses induced by T cell vaccination in patients with multiple sclerosis.
    Proc Natl Acad Sci U S A, 103(13): 5024-9. [Abstract] [Full-text]

© 2004-2012 Multiple Sclerosis Research Today. All Rights Reserved.